Rocuronium Bromide Injection
Product Images NDC 72572-650

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 72572-650). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Civica, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rocuronium Bromide Chemical Structure (Rocuronium Bromide Injection 1)

Chemical structure of Rocuronium Bromide showing its molecular framework including functional groups and bond arrangements.*

FDA Label Image

50 mg And 100 mg Same Sticker (Rocuronium Bromide Injection 10)

Label for Rocuronium Bromide Injection 10 mg/mL by Civica, Inc. The label instructs to apply to syringe and states it is for intravenous use only. It prominently displays that the product is a paralyzing agent and is Rx only.*

FDA Label Image

Layout 1 (Rocuronium Bromide Injection 11)

A black and white product label featuring a QR code and text fields for GTIN, serial number (SN), expiration date (EXP), and lot number (LOT). The label is designed for serialization and traceability but does not display specific drug information directly on the label.*

FDA Label Image

Figure 1: Time To 80% Or Greater Block Vs. Initial Dose Of Rocuronium Bromide By Age Group (median, 25th And 75th Percentile, And Individual Values) (Rocuronium Bromide Injection 2)

A scatter plot with box-and-whisker representations showing data distribution in minutes on the vertical axis, versus dosage in mg/kg on the horizontal axis, grouped by age ranges 18-64 years, 65 years and older, and 1-12 years. The chart depicts variability of response times across these dosages and age groups.*

FDA Label Image

Figure 2: Duration Of Clinical Effect Vs. Initial Dose Of Rocuronium Bromide By Age Group (median, 25th And 75th Percentile, And Individual Values) (Rocuronium Bromide Injection 3)

A scatter box plot depicting duration in minutes versus dosage mg/kg of Rocuronium Bromide injection for different age groups: 18-64 years, 65 years and older, 3 months to 1 year, and 1 to 12 years. The y-axis shows duration in minutes up to 160. The x-axis shows dosage in mg/kg ranges for each age group with scattered data points and boxes representing variability and median.*

FDA Label Image

Figure 3: Duration Of Clinical Effect Vs. Number Of Rocuronium Bromide Maintenance Doses, By Dose (Rocuronium Bromide Injection 4)

A line graph depicting the duration in minutes on the y-axis versus the dose number on the x-axis, comparing two dosages of Rocuronium Bromide injection, 0.10 mg/kg and 0.15 mg/kg. The graph shows data for 5 doses, with separate lines indicating the time course for each dosage level and respective sample sizes (N=29 for 0.10 mg/kg and N=13 for 0.15 mg/kg).*

FDA Label Image

72572-650-01 (Rocuronium Bromide Injection 5)

Label for Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) intravenous injection by Civica, Inc. The 5 mL multiple dose vial is marked as a paralyzing agent for intravenous use only. The label includes warnings, storage instructions, lot and expiration date fields, and the NDC 72572-650-01.*

FDA Label Image

72572-650-10 (Rocuronium Bromide Injection 6)

Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) label showing it is a human prescription intravenous injection by Civica, Inc. The label highlights the product's strength and multiple dose vials (10 x 5 mL). It includes a warning about respiratory arrest and the need for facilities to have artificial respiration available. Storage instructions state refrigeration at 2 to 8°C and no freezing. Manufacturer information is also present.*

FDA Label Image

50 mg And 100 mg Same Sticker (Rocuronium Bromide Injection 7)

Label for Rocuronium Bromide Injection, 10 mg/mL, for intravenous use. The label instructs to apply to syringe and prominently states it is a paralyzing agent. The labeler is Civica, Inc., and the product is prescription only.*

FDA Label Image

72572-651-01 (Rocuronium Bromide Injection 8)

The label is for Rocuronium Bromide Injection, 100 mg per 10 mL (10 mg/mL) concentration. It is a paralyzing agent for intravenous use only, supplied in a 10 mL multiple-dose vial. The label includes warnings about its use, storage instructions (store refrigerated 2° to 8°C), and manufacturing information indicating the labeler is Civica, Inc.*

FDA Label Image

72572-651-10 (Rocuronium Bromide Injection 9)

Rocuronium Bromide Injection 100 mg/10 mL (10 mg/mL) vial label distributed by Civica, Inc. The label includes warnings about respiratory arrest risk and instructions for storage at 2° to 8°C, not to freeze. It specifies the product is sterile, nonpyrogenic, for intravenous use only, and sold as 10 x 10 mL multiple dose vials. The label also details the composition per mL including rocuronium bromide and other components and cautions about artificial respiration availability.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.